Abstract:Electronic cigarettes (e-cigs) are popular nicotine delivery devices, yet the health effects remain unclear. To determine equivalent biomarkers, we characterized the immediate response in Apoe −/− mice exposed to tank/box-mod e-cig (e-cig tank ), pod e-cig (e-cig pod ), or cig smoke. Reproducible puff profiles were generated for each aerosol and delivered to Apoe −/− mice via a nose-only exposure system. Serum cotinine levels were quantified at various time points through ELISA and utilized to model cotinine pharmacokinetics. In addition, particle size measurements and mouse respiratory function were characterized to calculate particle dosimetry. Cig and e-cig tank particles were lognormally distributed with similar count median diameters (cig: 178 ± 2, e-cig tank : 200 ± 34nm), while e-cig pod particles were bimodally distributed and smaller (116 ± 13 and 13.3 ± 0.4 nm). Minute volumes decreased with cig exposure (5.4 ± 2.7 mL/min) compared to baseline (90.8 ± 11.6 mL/min), and less so with e-cig tank (45.2 ± 9.2 mL/min) and e-cig pod exposures (58.6 ± 6.8 mL/min), due to periods of apnea in the cig exposed groups. Cotinine was absorbed and eliminated most rapidly in the e-cig pod group ( tmax = 14.5; t1/2' = 51.9 min), whereas cotinine was absorbed (cig: 50.4, e-cig tank : 40.1 min) and eliminated (cig: 104.6, e-cig tank : 94.1 min) similarly in the cig and e-cig tank groups. For exposure times which equate the area under the cotinine-concentration curve, ∼6.4× (e-cig tank ) and 4.6× (e-cig pod ) more nicotine deposited in e-cig compared to cig exposed mice. This study provides a basis for incorporating cotinine pharmacokinetics into preclinical exposure studies, allowing for longitudinal studies of structural and functional changes due to exposure. This study highlights that pod e-cigs deliver smaller particles than tank/box-mode e-cigs and cig smoke. Minute volumes were substantially reduced in cig smoke-exposed mice, due to periods of apnea, whereas only expiration times increased in the e-cig-exposed groups. More particles deposit in e-cig exposed mice, compared to the cig group, for equivalent daily area under the cotinine concentration curve.

Assessment of nicotine release from nicotine-loaded chitosan nanoparticles dry powder inhaler formulations via locomotor activity of C57BL/6 mice

Nicotine Hydrogen Tartrate Loaded Chitosan Nanoparticles: Formulation, Characterization and in Vitro Delivery from Dry Powder Inhaler Formulation.

Pharmacokinetic Analysis of Nicotine and Its Metabolites (Cotinine and trans-3'-Hydroxycotinine) in Male Sprague-Dawley Rats Following Nose-Only Inhalation, Oral Gavage, and Intravenous Infusion of Nicotine

A convenient UHPLC-MS/MS method for routine monitoring of plasma and brain levels of nicotine and cotinine as a tool to validate newly developed preclinical smoking model in mouse

E-Cigarette Aerosol Deposition and Disposition of [11C]Nicotine Using Positron Emission Tomography: A Comparison of Nicotine Uptake in Lungs and Brain Using Two Different Nicotine Formulations

An e-cigarette aerosol generation, animal exposure and toxicants quantification system to characterize in vivo nicotine kinetics in arterial and venous blood

A mouse model for chronic intermittent electronic cigarette exposure exhibits nicotine pharmacokinetics resembling human vapers

Pharmacological and physiological response in Apoe−/− mice exposed to cigarette smoke or e-cigarette aerosols

Establishment of an Inhalation Administration Non-invasive Murine Model for Rapidly Testing Drug Activity against

Optimizing positive allosteric modulators to selectively target the high sensitivity 23 nicotinic acetylcholine receptor

Optimisation of an in vitro human cardiovascular model on-a-chip for toxicological assessment of nicotine delivery products

Multi-endpoint in vitro toxicological assessment of snus and tobacco-free nicotine pouch extracts

A 6-month inhalation toxicology study in Apoe−/− mice demonstrates substantially lower effects of e-vapor aerosol compared with cigarette smoke in the respiratory tract

Preparation of an environmentally friendly formulation of the insecticide nicotine hydrochloride through encapsulation in chitosan/tripolyphosphate nanoparticles.

Nanoparticles-in-microparticles Loaded with Lectin-Anchored Salmeterol Xinafoate: a Pharmacodynamics and Pharmacokinetics Study

Preparation and Evaluation of Mucus-Penetrating Inhalable Microparticles of Tiotropium Bromide Containing Sodium Glycocholate

Effect of chronic vapor nicotine exposure on affective and cognitive behavior in male mice

Assessing the Effects of Nicotinamide Mononucleotide Supplementation on Pulmonary Inflammation in Male Mice Subchronically Exposed to Ambient Particulate Matter

Assessment of nicotine delivery and uptake in users of various tobacco/nicotine products

Preparation and Transdermal Performance Study of a New S‐(‐)‐Nicotine‐Loaded Nano Flexible Liposome Hydrogel Patch with Long‐Lasting and Sustained Drug‐Release Effects

SR9883 is a novel small-molecule enhancer of α4β2* nicotinic acetylcholine receptor signaling that decreases intravenous nicotine self-administration in rats